Stephen J Williams1, Dusica Cvetkovic, Thomas C Hamilton. 1. Ovarian Cancer Program, Department of Medical Oncology, Fox Chase Cancer Center, 333 Cottman Avenue W310, Philadelphia, PA 19111, USA. SJ_Williams@fccc.edu
Abstract
OBJECTIVES: We have previously reported that loss in expression of a protein considered critical for vitamin A homeostasis, cellular retinol-binding protein 1 (CRBP1), is an early event in ovarian carcinogenesis. The aim of the present study was to determine if loss of vitamin A metabolism also occurs early in ovarian oncogenesis. METHODS: We assessed CRBP1 expression by immunohistochemistry in ovaries prophylactically removed from women with a genetic risk for ovarian cancer. Furthermore, we investigated the ability of normal, immortalized but nontumorigenic, and tumorigenic human ovarian epithelial cells to synthesize retinoic acid and retinaldehyde when challenged with a physiological dose of retinol, and determined expression levels of the retinoid-related genes, RARalpha, RXRalpha, CRABP1, CRABP2, RALDH1 and RALDH2 in these cells. RESULTS: Immunohistochemistry revealed loss of CRBP1 expression in potentially preneoplastic lesions in prophylactic oophorectomies. HPLC analysis of vitamin A metabolism showed production of retinoic acid in four independent, normal human ovarian surface epithelial (HOSE) cell cultures upon exposure to retinol. However, only one of two SV40-immortalized HOSE cell lines made RA, while none of the ovarian carcinoma cell lines produced detectable RA due to complete loss of RALDH2. CONCLUSIONS: The impaired conversion of retinol to RA in ovarian cancer cells and decreased CRBP1 protein expression in prophylactic oophorectomies support our hypothesis that concomitant losses of vitamin A metabolism and CRBP1 expression contribute to ovarian oncogenesis.
OBJECTIVES: We have previously reported that loss in expression of a protein considered critical for vitamin A homeostasis, cellular retinol-binding protein 1 (CRBP1), is an early event in ovarian carcinogenesis. The aim of the present study was to determine if loss of vitamin A metabolism also occurs early in ovarian oncogenesis. METHODS: We assessed CRBP1 expression by immunohistochemistry in ovaries prophylactically removed from women with a genetic risk for ovarian cancer. Furthermore, we investigated the ability of normal, immortalized but nontumorigenic, and tumorigenic human ovarian epithelial cells to synthesize retinoic acid and retinaldehyde when challenged with a physiological dose of retinol, and determined expression levels of the retinoid-related genes, RARalpha, RXRalpha, CRABP1, CRABP2, RALDH1 and RALDH2 in these cells. RESULTS: Immunohistochemistry revealed loss of CRBP1 expression in potentially preneoplastic lesions in prophylactic oophorectomies. HPLC analysis of vitamin A metabolism showed production of retinoic acid in four independent, normal human ovarian surface epithelial (HOSE) cell cultures upon exposure to retinol. However, only one of two SV40-immortalized HOSE cell lines made RA, while none of the ovarian carcinoma cell lines produced detectable RA due to complete loss of RALDH2. CONCLUSIONS: The impaired conversion of retinol to RA in ovarian cancer cells and decreased CRBP1 protein expression in prophylactic oophorectomies support our hypothesis that concomitant losses of vitamin A metabolism and CRBP1 expression contribute to ovarian oncogenesis.
Authors: A K Godwin; J R Testa; L M Handel; Z Liu; L A Vanderveer; P A Tracey; T C Hamilton Journal: J Natl Cancer Inst Date: 1992-04-15 Impact factor: 13.506
Authors: Peter W Schlosshauer; Carmel J Cohen; Frederique Penault-Llorca; Carlos R Miranda; Yves-Jean Bignon; Jacques Dauplat; Liane Deligdisch Journal: Cancer Date: 2003-12-15 Impact factor: 6.860
Authors: Keishi Yamashita; Sunil Upadhyay; Motonobu Osada; Mohammad O Hoque; Yan Xiao; Masaki Mori; Fumiaki Sato; Stephen J Meltzer; David Sidransky Journal: Cancer Cell Date: 2002-12 Impact factor: 31.743
Authors: Ellen L Goode; Kristin L White; Robert A Vierkant; Catherine M Phelan; Julie M Cunningham; Joellen M Schildkraut; Andrew Berchuck; Melissa C Larson; Brooke L Fridley; Janet E Olson; Penelope M Webb; Xiaoqing Chen; Jonathan Beesley; Georgia Chenevix-Trench; Thomas A Sellers Journal: Mol Carcinog Date: 2010-12-28 Impact factor: 4.784
Authors: Rong-Zong Liu; Shuai Li; Elizabeth Garcia; Darryl D Glubrecht; Ho Yin Poon; Jacob C Easaw; Roseline Godbout Journal: Glia Date: 2016-02-19 Impact factor: 7.452
Authors: Ekaterina S Kropotova; Olga L Zinovieva; Alisa F Zyryanova; Vera I Dybovaya; Vladimir S Prasolov; Sergey F Beresten; Nina Yu Oparina; Tamara D Mashkova Journal: Pathol Oncol Res Date: 2014-03-06 Impact factor: 3.201
Authors: Efterpi Kostareli; Dana Holzinger; Olga Bogatyrova; Thomas Hielscher; Gunnar Wichmann; Michaela Keck; Bernd Lahrmann; Niels Grabe; Christa Flechtenmacher; Christopher R Schmidt; Tanguy Seiwert; Gerhard Dyckhoff; Andreas Dietz; Daniela Höfler; Michael Pawlita; Axel Benner; Franz X Bosch; Peter Plinkert; Christoph Plass; Dieter Weichenhan; Jochen Hess Journal: J Clin Invest Date: 2013-05-01 Impact factor: 14.808